Act-Hib

Act-Hib is a vaccine designed to protect against Haemophilus influenzae type b (Hib) infections. This conjugate vaccine uses tetanus toxoid to enhance immune response, suitable for intramuscular or subcutaneous use.

Act-Hib is primarily used to prevent invasive diseases caused by Haemophilus influenzae type b, such as meningitis and sepsis. It is often administered to infants and young children as part of routine immunization schedules. The vaccine helps the body build immunity against Hib, which can cause serious infections.

Common effects of Act-Hib may include mild redness, swelling, or tenderness at the injection site. Some individuals might experience a low-grade fever or mild irritability. These effects are generally short-lived and resolve on their own.

Act-Hib should be administered by healthcare professionals. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid it. It is important to inform the healthcare provider about any current illnesses or allergies before receiving the vaccine.

Act-Hib may interact with other vaccines or medications, particularly those that affect the immune system. It is advisable to discuss any current medications or recent vaccinations with a healthcare provider before receiving Act-Hib.